Halter Ferguson Financial Inc. Has $4.65 Million Stock Holdings in Oscar Health, Inc. $OSCR

Halter Ferguson Financial Inc. boosted its position in Oscar Health, Inc. (NYSE:OSCR) by 4.2% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 405,732 shares of the company’s stock after buying an additional 16,335 shares during the period. Oscar Health makes up approximately 1.0% of Halter Ferguson Financial Inc.’s portfolio, making the stock its 12th biggest position. Halter Ferguson Financial Inc.’s holdings in Oscar Health were worth $4,654,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the company. Vanguard Group Inc. grew its stake in Oscar Health by 2.7% in the fourth quarter. Vanguard Group Inc. now owns 20,701,250 shares of the company’s stock valued at $297,477,000 after acquiring an additional 540,851 shares during the period. Geode Capital Management LLC raised its position in shares of Oscar Health by 2.5% during the fourth quarter. Geode Capital Management LLC now owns 4,798,313 shares of the company’s stock worth $68,964,000 after purchasing an additional 116,430 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH lifted its holdings in shares of Oscar Health by 1,097.8% in the 4th quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 237,882 shares of the company’s stock worth $3,418,000 after purchasing an additional 218,022 shares in the last quarter. BIT Capital GmbH lifted its holdings in shares of Oscar Health by 545.0% in the 4th quarter. BIT Capital GmbH now owns 6,186,267 shares of the company’s stock worth $88,897,000 after purchasing an additional 5,227,152 shares in the last quarter. Finally, Farallon Capital Management LLC grew its position in Oscar Health by 146.5% in the 3rd quarter. Farallon Capital Management LLC now owns 3,639,000 shares of the company’s stock valued at $68,886,000 after purchasing an additional 2,163,000 shares during the period. Institutional investors own 75.70% of the company’s stock.

Analyst Ratings Changes

A number of analysts have commented on the stock. UBS Group boosted their price target on shares of Oscar Health from $15.00 to $20.00 and gave the company a “neutral” rating in a research note on Thursday, May 7th. Wall Street Zen upgraded shares of Oscar Health from a “buy” rating to a “strong-buy” rating in a report on Sunday, June 14th. Robert W. Baird boosted their target price on shares of Oscar Health from $15.00 to $19.00 and gave the stock a “neutral” rating in a research report on Thursday, May 7th. Jefferies Financial Group upgraded shares of Oscar Health from an “underperform” rating to a “hold” rating and upped their target price for the stock from $10.00 to $16.00 in a report on Monday, April 20th. Finally, Wolfe Research assumed coverage on shares of Oscar Health in a research report on Tuesday, May 5th. They issued a “peer perform” rating on the stock. Three investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, Oscar Health has a consensus rating of “Hold” and a consensus target price of $20.78.

Oscar Health Trading Down 2.5%

Shares of Oscar Health stock opened at $31.39 on Tuesday. The stock has a fifty day simple moving average of $24.79 and a 200 day simple moving average of $17.99. Oscar Health, Inc. has a 12-month low of $10.69 and a 12-month high of $33.10. The company has a market capitalization of $9.46 billion, a P/E ratio of -53.20, a price-to-earnings-growth ratio of 2.25 and a beta of 2.34. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of 0.26.

Oscar Health (NYSE:OSCR) last released its quarterly earnings results on Wednesday, May 6th. The company reported $2.07 EPS for the quarter, beating analysts’ consensus estimates of $1.11 by $0.96. Oscar Health had a negative return on equity of 3.26% and a negative net margin of 0.30%.The business had revenue of $4.65 billion during the quarter, compared to analyst estimates of $4.90 billion. During the same period in the prior year, the firm posted $0.92 EPS. Oscar Health’s quarterly revenue was up 52.6% compared to the same quarter last year. On average, sell-side analysts anticipate that Oscar Health, Inc. will post 0.47 earnings per share for the current fiscal year.

Insider Transactions at Oscar Health

In related news, CEO Mark T. Bertolini sold 624,244 shares of the firm’s stock in a transaction dated Tuesday, June 30th. The shares were sold at an average price of $28.48, for a total transaction of $17,778,469.12. Following the transaction, the chief executive officer directly owned 7,751,570 shares of the company’s stock, valued at $220,764,713.60. This trade represents a 7.45% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Janet Liang sold 12,475 shares of the business’s stock in a transaction dated Tuesday, June 2nd. The stock was sold at an average price of $21.94, for a total transaction of $273,701.50. Following the transaction, the insider owned 259,057 shares in the company, valued at approximately $5,683,710.58. This trade represents a 4.59% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last 90 days, insiders have sold 3,662,466 shares of company stock worth $105,145,815. 25.11% of the stock is owned by insiders.

Oscar Health Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.